Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 5 Ovarian Neoplasms 3 Lung Neoplasms 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Lymphoma 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Adenocarcinoma 2 Urticaria 1 Tuberous Sclerosis 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Severe Combined Immunodeficiency 1 Salivary Gland Neoplasms 1 Renal Insufficiency, Chronic 1 Rectal Neoplasms 1 Pancreatitis, Chronic 1 Pancreatitis 1 Pancreatic Cyst 1 Non-alcoholic Fatty Liver Disease 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Nephritis 1 Neoplasm Metastasis 1 Multiple Sclerosis 1 Mucopolysaccharidosis I 1 Melanoma 1

Interventions

Surveys and Questionnaires 1 Sunitinib 1 Sorafenib 1 Phlebotomy 1 Pancreatectomy 1 Histocompatibility Testing 1 Gefitinib 1 Everolimus 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Blood Specimen Collection 1 Biopsy, Large-Core Needle 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Adenoma, Islet Cell × Phlebotomy × Clear all

NCT03741517 2022-05-18

Biomarker Study of Pancreatic Neuroendocrine Tumours

Uppsala University

Adenoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡